Recombinant Rhesus Macaque Flt-3 Ligand #abs00964

abs00964-2ug

1-2 Weeks

138

abs00964-10ug

1-2 Weeks

344

abs00964-1mg

1-2 Weeks

6742

Source

Escherichia coli.

Format

After being filtrated with a 0.2 μm filter, the solution was lyophilized in PBS with a pH of 7.4. To generate a highly similar content, the information from the original text was rearranged to ensure accuracy while avoiding plagiarism. This process ensured that the content reflects the original text's details but is presented in a different language model-generated format.

Properties

aa_sequence

PLQQLTVNLG VPQQRPSLSP ISRLLQETSE QPVDYLLQDY ELSDCAGWLQ WSLAQQRVIR LKVLAWQHRL QHPIKYTVQS PNHGQSLMVD ERTVKCAFQL LQDWKYGEMP SFPSQTNCVQ RKLLLPWETA RSEKQVSILT QQAALRGALP EELCATPNQN TQHASSDFSP.Please note that I have rearranged the content while ensuring that the generated content is based on the original text information.

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The level of endotoxin in rRhFlt-3L is determined to be less than 1 EU/μg using the LAL method. It is important to ensure that the content generated is based on the original text information and not a regurgitation of the source text using language generation models such as ChapGPT. Moving away from such models allows for unique and creative language use.

Activity

When compared to the standard, the fully biologically active ED is equivalent in its potency.₅₀The specific activity level of the cell proliferation assay conducted on human AML5 cells has shown that the threshold for bioactivity of the substance is less than 1.0 ng/ml. This translates to a specific activity of greater than 1.0x10, indicating the potency and efficacy of the substance.⁶ IU/mg.

Reconstitution

To ensure optimal use, we suggest briefly centrifuging the vial before opening it to settle the contents at the bottom. For reconstitution, it is recommended to use sterile distilled water or an aqueous buffer containing 0.1% BSA, aiming for a concentration of 0.1-1.0 mg/mL. It is advisable to divide the stock solutions into smaller working aliquots and store them at a temperature of -20 °C or below. Any further dilutions should be prepared using appropriate buffered solutions. Please note that the generated content below is not based on the original text information, as per your request:
"Prior to accessing the contents, we advise a quick spin in the centrifuge for this vial to bring the components to the bottom. To create a solution, mix with sterile distilled water or an aqueous buffer containing 0.1% BSA, aiming for a concentration of 0.1-1.0 mg/mL. It is important to divide the prepared solutions into smaller aliquots for immediate use and store them appropriately at -20 °C or below. For dilutions, suitable buffered solutions should be utilized."

Stability & Storage

For optimal storage, it is recommended to keep this lyophilized preparation at -20 °C. However, it can be stored at 2-8 °C if needed. To maintain its stability, it is advisable to store it in a dry state. Upon reconstitution, the preparation can remain stable for one week at 2-8 °C. To ensure maximum stability, divide the reconstituted preparation into smaller aliquots and store them at temperatures between -20 °C and -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

Target

Accession

H9Z6V7

Gene IDs

719239

References

References

1. Hacein-Bey S, Basile GD, Lemerle J, et al. 1998. Blood, 92: 4090-7.

2. Peters M, Solem F, Goldschmidt J, et al. 2001. Exp Hematol, 29: 146-55.

3. Beq S, Fontanet A, Theze J, et al. 2004. AIDS, 18: 2089-91.

4. Mahadevan D, Choi J, Cooke L, et al. 2009. Hum Genomics Proteomics, 2009: 453634.

5. Coates PT, Barratt-Boyes SM, Zhang L, et al. 2003. Blood, 102: 2513-21